Author

Ana Blas-Garcia 1

1 Pharmacology, Universidad De Valencia-Ciberehd, Valencia, Spain;fisabio-Hospital Universitario Dr. Peset, Valencia, Spain

ABACAVIR AND DIDANOSINE ENHANCE ACETAMINOPHEN-INDUCED HEPATOTOXICITY THROUGH GSH DEPLETION

Ana Blas-Garcia, Víctor Víctor, Miriam Polo, Haryes Funes, Alberto Martí-Rodrigo, Nadezda Apostolova, Juan V. Esplugues

IS SQSTM1/P62 A DEFENCE AGAINST EFV-INDUCED HEPATOTOXICITY?

Fernando Alegre Guerra, Ana Blas-Garcia, Miriam Polo, Haryes Funes, Nadezda Apostolova, Juan V. Esplugues

RILPIVIRINE-INDUCED ANTI-INFLAMMATORY EFFECTS IN LIVER DISEASES INVOLVE THE ACTIVATION OF STAT6 SIGNALING PATHWAYS IN MACROPHAGES

Ángela Beatriz Moragrega, Alberto Martí-Rodrigo, Aleksandra Gruevska, Juan V. Esplugues, Nadezda Apostolova, Ana Blas-Garcia

Selective activation of STAT1-dependent apoptosis in hepatic stellate cells by rilpivirine as a new therapeutic option for liver fibrosis

Alberto Martí-Rodrigo, Ángela Beatriz Moragrega, Aleksandra Gruevska, Anabel Fernández-Iglesias, Jordi Gracia-Sancho, Juan V. Esplugues, Nadezda Apostolova, Ana Blas-Garcia

THE ANTIRETROVIRAL DRUG RILPIVIRINE DIMINISHES IP-10/CXCL10 EXPRESSION: RELEVANCE IN THE CONTEXT OF LIVER DISEASE

Joan Tosca, Aleksandra Gruevska, Federico Lucantoni, Ángela Beatriz Moragrega, Juan V. Esplugues, Nadezda Apostolova, Ana Blas-García

THE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR EFAVIRENZ MODIFIES THE INFLAMMATORY RESPONSE OF HEPATIC CELLS

Ana Blas-Garcia, Fernando Alegre Guerra, Dolores Ortiz-Masia, Lara Milián-Medina, Nadezda Apostolova, Juan V. Esplugues

UNDERSTANDING THE TRANSCRIPTOMIC CHANGES OF MAFLD IN HIGH FAT DIET MURINE MODELS AND ITS REVERSION BY ANTI-STEATOTIC TREATMENTS THROUGH META-ANALYSIS

José F. Català-Senent, Francisco J. Roig, Juan V. Esplugues, Nadezda Apostolova, Francisco García-García, Isabel Fuster Martínez, Ana Blas-García

Item 1 - 7 / 7
1